By Artem Andrianov, Ph.D., MBA| 2014-02-23T15:45:48+00:00 February 23, 2014|Comments Off on 23-01-2014 11-01-03
About the Author: Artem Andrianov, Ph.D., MBA
Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.